Neurometabolic Profile of Tobacco Smoking in HIV-Infected Individuals

Neurometabolic Profile of Tobacco Smoking in HIV-Infected Individuals

Contact

 If you are interested in participating in the study or want to learn more, please get in touch. Contact us
This study is now recruiting. Learn more about enrolling here.

Description
HIV infection can cause harm to the brain and negatively affect memory, learning, and decision making in daily activities. Smoking may affect the ability of medications to reduce HIV in the bloodstream (viral load), which may affect long-term survival and brain health. This study will look for changes in the brain that might have occurred due to HIV infection or smoking. 

Eligibility and criteria
IRB Number:
23-021422
Eligible age range:
18 years - 75 years
Clinical trial phase:
N/A
Official title:
Neurometabolic Profile of Tobacco Smoking in HIV-Infected Individuals

What to expect
  • Psychological Tests and Questionnaires (including questionnaire about illicit drug use)
  • Drug Screen: Urine drug testing is part of the study. Those who self-report illicit drug use will not be able to participate. We will also measure smoking levels in your breath using an exhaling machine
  • HIV testing for subjects who do not have HIV will be performed
  • MRI Scan

Related specialties
Smiling CHOP patient holding shopping bag

We need families like you

Your time and participation make a difference in supporting the work of the Research Institute and children in our community. Learn more about opportunities to participate in our research.